Switching Anticoagulants After Breakthrough Stroke May Not Improve Outcomes - Top-Institutions - MDSpire

Switching Anticoagulants After Breakthrough Stroke May Not Improve Outcomes

Registry-based analysis found no short-term advantage to changing therapy following ischemic stroke in patients with atrial fibrillation

  • By

  • Andrea Surnit

  • April 30, 2026

  • 4 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurology
    • Hematology
    • Cardiology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Cardiology
    • Hematology

  • #3

    University of Oxford
    University of Oxford

    Oxford, Oxfordshire

    Key Differentiators

    • Neurology
    • Hematology
    • Epidemiology

  • #4

    Charité – Universitätsmedizin Berlin
    Charité – Universitätsmedizin Berlin

    Berlin, Berlin

    Key Differentiators

    • Neurology
    • Hematology
    • Clinical Pharmacology

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Neurology
    • Cardiology
    • Hematology

Original Source(s)

Switching Anticoagulants After Breakthrough Stroke May Not Improve Outcomes

  • by Andrea Surnit

  • April 30, 2026

Related Content

Intermittent theta burst stimulation enhances the efficacy of brain–computer interface in upper limb rehabilitation post-stroke

The effect of probiotic supplements on cognitive outcomes and neuroplasticity in elderly ischemic stroke survivors

Nomogram-based prediction of hemorrhagic transformation risk integrating platelet-to-white blood cell ratio in patients with acute ischemic stroke after intravenous thrombolysis